BACKGROUND: Calls for better end-of-life care for advanced chronic obstructive pulmonary disease (COPD) reflect the large number who die from the disease and their considerable unmet needs. AIM: To determine palliative care needs in advanced COPD. DESIGN: Cross-sectional interview study in patients' homes using structured questionnaires generated from 44 south London general practices. METHOD: One hundred and sixty-three (61% response) patients were interviewed, mean age 72 years, 50% female, with diagnosis of COPD and at least two of: forced expiratory volume in the first second (FEV(1)) <40% predicted, hospital admissions or acute severe exacerbations with COPD, long-term oxygen therapy, cor pulmonale, use of oral steroids, and being housebound. Patients with advanced cancer, severe alcohol-related or mental health problems, or learning difficulties, were excluded; 145 patients were included in the analysis. RESULTS: One hundred and twenty-eight (88%) participants reported shortness of breath most days/every day, 45% were housebound, 75% had a carer. Medical records indicated that participants were at least as severe as non-participants. Eighty-two (57%) had severe breathlessness; 134 (92%) said breathlessness was their most important problem; 31 (21%) were on suboptimal treatment; 42 (30%) who were severely affected had not been admitted to hospital in the previous 2 years; 86 of 102 who had been admitted would want admission again if unwell to the same extent. None expressed existential concerns and few discussed need in terms of end-of-life care, despite severe breathlessness and impairment. CONCLUSION: Needs in advanced COPD were considerable, with many reporting severe intractable breathlessness. Palliation of breathlessness was a priority, but discussion of need was seldom in terms of 'end-of-life care'.
BACKGROUND: Calls for better end-of-life care for advanced chronic obstructive pulmonary disease (COPD) reflect the large number who die from the disease and their considerable unmet needs. AIM: To determine palliative care needs in advanced COPD. DESIGN: Cross-sectional interview study in patients' homes using structured questionnaires generated from 44 south London general practices. METHOD: One hundred and sixty-three (61% response) patients were interviewed, mean age 72 years, 50% female, with diagnosis of COPD and at least two of: forced expiratory volume in the first second (FEV(1)) <40% predicted, hospital admissions or acute severe exacerbations with COPD, long-term oxygen therapy, cor pulmonale, use of oral steroids, and being housebound. Patients with advanced cancer, severe alcohol-related or mental health problems, or learning difficulties, were excluded; 145 patients were included in the analysis. RESULTS: One hundred and twenty-eight (88%) participants reported shortness of breath most days/every day, 45% were housebound, 75% had a carer. Medical records indicated that participants were at least as severe as non-participants. Eighty-two (57%) had severe breathlessness; 134 (92%) said breathlessness was their most important problem; 31 (21%) were on suboptimal treatment; 42 (30%) who were severely affected had not been admitted to hospital in the previous 2 years; 86 of 102 who had been admitted would want admission again if unwell to the same extent. None expressed existential concerns and few discussed need in terms of end-of-life care, despite severe breathlessness and impairment. CONCLUSION: Needs in advanced COPD were considerable, with many reporting severe intractable breathlessness. Palliation of breathlessness was a priority, but discussion of need was seldom in terms of 'end-of-life care'.
Authors: M R Miller; J Hankinson; V Brusasco; F Burgos; R Casaburi; A Coates; R Crapo; P Enright; C P M van der Grinten; P Gustafsson; R Jensen; D C Johnson; N MacIntyre; R McKay; D Navajas; O F Pedersen; R Pellegrino; G Viegi; J Wanger Journal: Eur Respir J Date: 2005-08 Impact factor: 16.671
Authors: M Bednarek; D Gorecka; J Wielgomas; M Czajkowska-Malinowska; J Regula; G Mieszko-Filipczyk; M Jasionowicz; R Bijata-Bronisz; M Lempicka-Jastrzebska; M Czajkowski; G Przybylski; J Zielinski Journal: Thorax Date: 2006-06-29 Impact factor: 9.139
Authors: Eléonore F van Dam van Isselt; Karin H Groenewegen-Sipkema; Monica Spruit-van Eijk; Niels H Chavannes; Margot W M de Waal; Daisy J A Janssen; Wilco P Achterberg Journal: BMJ Open Date: 2014-09-26 Impact factor: 2.692
Authors: Timothy E Albertson; Michael Schivo; Amir A Zeki; Samuel Louie; Mark E Sutter; Mark Avdalovic; Andrew L Chan Journal: Drugs Aging Date: 2013-07 Impact factor: 3.923
Authors: Mette Bech Risør; Mark Spigt; R Iversen; M Godycki-Cwirko; N Francis; A Altiner; E Andreeva; K Kung; H Melbye Journal: BMJ Open Date: 2013-12-05 Impact factor: 2.692
Authors: Ulugbek Nurmatov; Susan Buckingham; Marilyn Kendall; Scott A Murray; Patrick White; Aziz Sheikh; Hilary Pinnock Journal: PLoS One Date: 2012-10-23 Impact factor: 3.240
Authors: Emma Mi; Ella Mi; Gail Ewing; Patrick White; Ravi Mahadeva; A Carole Gardener; Morag Farquhar Journal: Int J Chron Obstruct Pulmon Dis Date: 2018-03-22